Matthew Wikler

Corporate Officer/Principal chez IDTD Consulting SASU

Profil

Matthew A. Wikler currently works at IDTD Consulting SASU, as Principal from 2015.
Dr. Wikler also formerly worked at Shire ViroPharma, Inc., as President & Chief Executive Officer, Ortho-McNeil Pharmaceutical LLC, as President & Chief Executive Officer, Clinical & Laboratory Standards Institute, Inc. (Pennsylvania), as Vice Chairman, Bristol Myers Squibb Co., as Senior Medical Director-Infectious Diseases from 1997 to 2001, US Food & Drug Administration, as Deputy Director-Anti-infective Drug Products from 1994 to 1995, ID Care PA, as Vice President & Medical Director, Matinas BioPharma Holdings, Inc., as Independent Director from 2018 to 2025, The Medicines Co., as Vice President-New Business Ventures from 2012 to 2015, Peninsula Pharmaceuticals, Inc., as Chief Medical Officer & Executive Vice President in 2005, IASO Pharma, Inc., as President, Chief Executive & Financial Officer, MPEX Pharmaceuticals, Inc., as Chief Medical Officer in 2006, PATH Drug Solutions, as Chief Medical Officer in 2010, Melinta Subsidiary Corp., as Chief Development Officer in 2012, and Viropharma, Inc., as Principal.
Dr. Wikler received his undergraduate degree from Franklin & Marshall College, Masters Business Admin degree from The Wharton School of the University of Pennsylvania, and doctorate degree from Temple University School of Medicine.

Postes actifs de Matthew Wikler

Sociétés	Poste	Début
IDTD Consulting SASU	Corporate Officer/Principal	01/06/2015

Anciens postes connus de Matthew Wikler

Sociétés	Poste	Fin
MATINAS BIOPHARMA HOLDINGS, INC.	Directeur/Membre du Conseil	11/03/2025
THE MEDICINES COMPANY	Corporate Officer/Principal	01/01/2015
Melinta Subsidiary Corp.	Corporate Officer/Principal	01/08/2012
PATH Drug Solutions	Directeur Technique/Scientifique/R&D	26/02/2010
MPEX Pharmaceuticals, Inc.	Directeur Technique/Scientifique/R&D	01/11/2006